Innovations

SPIDER-Deprescribing

 

Polypharmacy increases the likelihood of adverse drug reactions. Join a national initiative on deprescribing to reduce potentially inappropriate medications in elderly patients.

According to the Canadian Institute for Health Information, more than one in four Canadians 65 years of age or older are prescribed over ten unique medications per year.

Would you like assistance in reducing potentially inappropriate medications in your elderly patients? Join forces with the Ottawa Practice Enhancement Network (OPEN) and other primary care practice networks across Canada to study the SPIDER (a Structured Process Informed by Data, Evidence and Research) approach in deprescribing unnecessary medications in complex elderly patients.

The SPIDER study:

  • Aligns with Choosing Wisely

  • Helps practices meet Quality Improvement Plan expectations

 

There is no cost to you for participating in the SPIDER study, and the College of Family Physicians of Canada has certified our Launch Collaborative workshop for up to 9 MainPro+ credits.

Supporting Practices Re-Open Post-COVID-19

 

Priority-based care involves addressing the needs of individuals with higher risk levels for poor outcomes first.

As healthcare services previously suspended due to the pandemic re-open, and primary care practices commence their return to “usual practice”, they will be faced with the need to prioritize care service delivery that are currently backlogged, and deal with the consequences of the pandemic on their patients.

Our COVID-19 project aims to support practices implement a strategy for priority-based care in their post-pandemic care delivery that integrates social factors to the usual health factors in establishing the individual’s risks and priority level.

Linking Census Data to EMR Data

 

Identifying appropriate measures of deprivation for use with CPCSSN data.


We are linking patients' electronic medical record data to their neighborhood level profile on the social determinants of health to allow a more comprehensive assessment of patient risk levels.